ArticleFrontiers in immunology2026

Identification of public neoantigens with broad HLA class I coverage as candidates for off-the-shelf cancer vaccine development in colorectal cancer.

Diem Tp Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.